[go: up one dir, main page]

IL43022A0 - An oral pharmaceutical composition containing cholestyramine coacervate - Google Patents

An oral pharmaceutical composition containing cholestyramine coacervate

Info

Publication number
IL43022A0
IL43022A0 IL43022A IL4302273A IL43022A0 IL 43022 A0 IL43022 A0 IL 43022A0 IL 43022 A IL43022 A IL 43022A IL 4302273 A IL4302273 A IL 4302273A IL 43022 A0 IL43022 A0 IL 43022A0
Authority
IL
Israel
Prior art keywords
coacervate
pharmaceutical composition
composition containing
oral pharmaceutical
containing cholestyramine
Prior art date
Application number
IL43022A
Other versions
IL43022A (en
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL43022A0 publication Critical patent/IL43022A0/en
Publication of IL43022A publication Critical patent/IL43022A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
IL43022A 1972-09-01 1973-08-20 An oral pharmaceutical composition containing cholestyramine coacervate IL43022A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28571972A 1972-09-01 1972-09-01

Publications (2)

Publication Number Publication Date
IL43022A0 true IL43022A0 (en) 1974-01-14
IL43022A IL43022A (en) 1976-07-30

Family

ID=23095432

Family Applications (1)

Application Number Title Priority Date Filing Date
IL43022A IL43022A (en) 1972-09-01 1973-08-20 An oral pharmaceutical composition containing cholestyramine coacervate

Country Status (7)

Country Link
CA (1) CA1014472A (en)
DE (1) DE2344090A1 (en)
FR (1) FR2197592B1 (en)
GB (1) GB1446352A (en)
IL (1) IL43022A (en)
NL (1) NL7311319A (en)
ZA (1) ZA736016B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4914084A (en) * 1984-05-09 1990-04-03 Synthetic Blood Corporation Composition and method for introducing heme, hemoproteins, and/or heme-hemoprotein complexes into the body
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
US4804548A (en) * 1984-10-05 1989-02-14 Warner-Lambert Company Novel sweetener delivery systems
US4828857A (en) * 1984-10-05 1989-05-09 Warner-Lambert Company Novel sweetener delivery systems
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
IT1190349B (en) * 1986-06-16 1988-02-16 Prodotti Formenti Srl PHARMACEUTICAL COMPOSITIONS WITH SEQUESTRANT ACTIVITY OF BILE ACIDS CONTAINING COLESTYRAMINE AS THE ACTIVE INGREDIENT, AND PROCEDURE TO PREPARE THEM
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
CA1313135C (en) * 1987-02-09 1993-01-26 The Dow Chemical Company Cholestyramine composition and process for its preparation
US5167965A (en) * 1987-02-09 1992-12-01 The Dow Chemical Company Palatable cholestyramine granules, tablets and methods for preparation thereof
EP0349103B1 (en) * 1988-05-04 1992-11-25 Smith Kline & French Laboratories Limited Chewable tablet
US4931280A (en) * 1988-06-13 1990-06-05 Basf K & F Corporation Edible, baked compositions containing cholestyramine
US5275823A (en) * 1989-04-27 1994-01-04 Smith Kline & French Laboratories Ltd. Pharmaceutical compositions
US5102664A (en) * 1989-07-19 1992-04-07 Day Charles E Good-tasting gritty drug formulations
KR100221396B1 (en) * 1990-12-20 1999-09-15 데이비드 엠 모이어 Composition of plantain and cholestyramine with improved aesthetics
AU3812893A (en) * 1992-03-20 1993-10-21 Procter & Gamble Company, The Anion exchange resin compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3499960A (en) * 1965-01-25 1970-03-10 Merck & Co Inc Palatable coated particles of an anion exchange resin

Also Published As

Publication number Publication date
DE2344090A1 (en) 1974-03-21
FR2197592A1 (en) 1974-03-29
FR2197592B1 (en) 1976-08-13
NL7311319A (en) 1974-03-05
GB1446352A (en) 1976-08-18
AU5946073A (en) 1975-02-27
CA1014472A (en) 1977-07-26
IL43022A (en) 1976-07-30
ZA736016B (en) 1975-04-30

Similar Documents

Publication Publication Date Title
IL42430A0 (en) Pyridopyrrolobenzheterocycles,their preparation and pharmaceutical compositions containing them
IL43022A0 (en) An oral pharmaceutical composition containing cholestyramine coacervate
ZA731808B (en) Pharmaceutical compositions
ZA733811B (en) Pharmaceutical compositions containing cysteine
ZA732438B (en) Pharmaceutical composition
IL43837A0 (en) New aminophenyl-ethanolamines and corresponding oxazolidines,their preparation and pharmaceutical compositions containing them
IL43722A0 (en) Novel 2-aminomethyleneindanones and pharmaceutical compositions containing them
IL43766A0 (en) Pharmaceutical compositions containing bis-phenolalkane derivatives
IL42429A0 (en) 2-alkoxycephalosporins,their preparation and pharmaceutical compositions containing them
AU5561973A (en) Pharmaceutical composition incorporating carnitine pharmaceutical composition incorporating carnitine
IE38280L (en) Pharmaceutical composition containing a 1,2,4-triazole¹derivative
MY7700009A (en) Pharmaceutical compositions containing bischromonyloxy compounds
ZA734996B (en) Oral composition
PH11231A (en) Piperidinesulfonylurea derivatives and pharmaceutical compositions containing them
AU5731773A (en) 2-oxo-indoline compounds and pharmaceutical compositions
ZA731012B (en) Pharmaceutical compositions
IL40747A0 (en) 1-phenyl-3-hydroxy-3-methyl-triazenes,their preparation and pharmaceutical compositions containing them
IL42790A0 (en) 4a-aryl-trans-decahydroisoquino-lines,their preparation and pharmaceutical compositions containing them
IL42613A0 (en) Amino-imidazo-and amino-pyrazolo-isoquinolines,their preparation and pharmaceutical compositions containing them
ZA732439B (en) Pharmaceutical composition
IL42560A0 (en) 3-amino-pyrazol-5-ones and their salts their manufacture and pharmaceutical compositions containing them
IL41564A0 (en) Pharmaceutical compositions containing n-cyclohexyl-benzylamine derivatives
CY940A (en) Pharmaceutical formulations
ZA734331B (en) Pharmaceutical compositions
IL42509A0 (en) Diisoquinolyl-dipyridyl-butanes,and their salts their manufacture and pharmaceutical compositions containing them